NCT00196885 Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training Status COMPLETED Phase PHASE2
NCT00187161 Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL Status COMPLETED Phase PHASE2
NCT00185965 CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas Status COMPLETED Phase PHASE1/PHASE2
NCT00177554 Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma Status COMPLETED Phase PHASE2
NCT00152139 Stem Cell Transplantation for Patients With Hematologic Malignancies Status COMPLETED Phase PHASE3
NCT00143559 Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT00103779 A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00100737 Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin's Lymphoma (NHL) Status TERMINATED Phase PHASE2
NCT00096161 Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00089596 Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT00039910 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia Status COMPLETED Phase PHASE3
NCT00026910 Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma Status COMPLETED Phase N/A
NCT00019708 Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE1